Armata Pharmaceuticals (ARMP) Amortizatization of Intangibles (2013 - 2014)

Armata Pharmaceuticals (ARMP) reported Amortizatization of Intangibles of $8000.0 for Q1 2014, down 97.43% on a YoY basis from $311000.0 in Q1 2013, and up 900.0% sequentially from -$1000.0 in Q4 2013.

Armata Pharmaceuticals (ARMP) Amortizatization of Intangibles (2013 - 2014) Analysis & Trends

Armata Pharmaceuticals (ARMP) has 2 years of Amortizatization of Intangibles data on file, last reported at $8000.0 in Q1 2014.

  • For the quarter ending Q1 2014, Amortizatization of Intangibles fell 97.43% year-over-year to $8000.0; the trailing twelve-month figure through Dec 2014 stood at $8000.0 (down 99.7% YoY), and the FY2013 full-year result was $2.6 million, changed N/A from the prior year.
  • Amortizatization of Intangibles grew to $8000.0 in Q1 2014, from -$1000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.3 million in Q2 2013 to a low of -$1000.0 in Q4 2013.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Armata Pharmaceuticals 187.95 Mn 183.15 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2014 8,000.00
Mar 31, 2014 8,000.00
Dec 31, 2013 -1,000.00
Dec 31, 2013 -1,000.00
Jun 30, 2013 2.33 Mn
Jun 30, 2013 2.33 Mn
Mar 31, 2013 311,000.00
Mar 31, 2013 311,000.00